4UIW

BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2015-04-22	Initial release
1.1	2016-03-09		Database references
1.2	2019-05-15		Advisory, Data collection, Experimental preparation, Other	exptl_crystal_grow, pdbx_database_proc, pdbx_database_status, pdbx_unobs_or_zero_occ_atoms
1.3	2024-05-08		Advisory, Data collection, Database references, Derived calculations, Other	chem_comp_atom, chem_comp_bond, database_2, pdbx_database_status, pdbx_unobs_or_zero_occ_atoms, struct_site	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.